Solitary Fibrous Tumor : Phase II Study on Trabectedin Versus Adriamycin Plus Dacarbazine in Advanced Patients .
ClinicalTrials Identifier : NCT03023124 .
Updated : 2017_01_17 .
Estimated Enrollment : 50 .
Study Start Date : March 2017 .
Administrative Data :
Organization name : Italian Sarcoma Group .
Organization study ID : ISG STRADA 2016 .
Sponsor : Italian Sarcoma Group .
Health Authority : Italy : The Italian Medicines Agency .
...